GSEA analysis suggested patients with high-DDX39 expression had short survival time, patients with low-DDX39 expression had long survival time (Supplemental Fig. 1B), suggesting DDX39 might be a prognostic factor for HCC patients. Here, DDX39A is linked to hepatocellular carcinoma.